Interaction of Red Cell Indices and Blood Group in Diabetic Patients above 50 Years of Age
Moore-Igwe Beatrice W. *
Department of Medical Laboratory Science, Faculty of Science, Rivers State University, Nkpolu-Oroworukwo, P.M.B. 5080, Port-Harcourt, Rivers State, Nigeria.
Ken-Ezihuo Stella U.
Department of Medical Laboratory Science, Faculty of Science, Rivers State University, Nkpolu-Oroworukwo, P.M.B. 5080, Port-Harcourt, Rivers State, Nigeria.
Baribefe Banavule Daniel Koate
Department of Medical Laboratory Science, Faculty of Science, Rivers State University, Nkpolu-Oroworukwo, P.M.B. 5080, Port-Harcourt, Rivers State, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Introduction: A group of metabolic diseases with a hyperglycemic phenotype known as diabetes mellitus impact both industrialized and developing nations. It is brought on by deviations in insulin synthesis, action, or both.
Research Objective: This study seeks to associate the interaction of red cell indices and blood group in diabetic patients above 50 years of age. This is a case control study in which a convenient sample size of 100 individuals were recruited from a consenting population at a private hospital in Port Harcourt, Rivers State, 50 of whom were diabetic, and the remaining 50 were not.
Methods: Using the automated 3-part differential hematology analyzer Sysmex KX-21N, a Full blood count (FBC) and differential was obtained using (Sysmex Corporation Kobe, Japan) Standardization, instrument calibration, and analysis of sample was achieved in line with accordance with the manufacturer's manual to determine the red cell indices and grouping of cells using the tile approach to determine the ABO Blood Groups. Blood samples were taken from the veins using a vacutainer tube and needle according to Chesbrough's instructions, and then put in EDTA anticoagulated bottles with clear labelling. These samples were transported right away using the triple packing procedure to the lab and stored until testing at 4°C. Inferential statistics utilizing the students' statistical t-test were employed to compare the results.
Results: Blood group O, with a total of 25 (50%), had the highest prevalence of diabetes mellitus, followed by blood group A with a total of 12 subjects (24%) and blood group B with a total of 8 subjects (16%) and blood group AB came in last with a total of 5 participants (10%), respectively. In this study, blood group O predominated over blood groups A and B (47% against 25% versus 17%, respectively). The least common blood type in this study was AB (11%). When the Packed Cell Volume, Haemoglobin, Red Blood Cell, Mean Cell volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration, and Red cell Distribution Width were examined between diabetic and non-diabetic participants, no statistically significant (p<0.05) difference was found.
Conclusion: The findings of this study suggest that blood types O and AB are more prevalent in diabetics. We can deduce that a person's blood type may be a risk factor for developing this condition and may be useful in diagnosing it.
Keywords: Interaction, diabetes, red cell indices, ABO blood groups
How to Cite
References
WHO. Expert Committee on the Selection, Use of Essential Medicines, World Health Organization. The Selection and Use of Essential Medicines: Report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children). World Health Organization; 2014.
Wokoma FS. Diabetes and hypertension in Africa, an overview. Diabetes international. 2002;12(12):36-40.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care. 2004 May 1;27(5):1047-53.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019 Nov 1;157:107843.
Desisto CL, Kim SY, Sharma AJ. Peer reviewed: Prevalence estimates of gestational diabetes mellitus in the United States, pregnancy risk assessment monitoring system (prams), 2007–2010. The Lancet. 2014;11(2):541–549.
Anifowoshe AT, Owolodun OB, Akinseye KM, Iyioloa OA, Oyeyemi BF. Gene frequencies of ABO and Rh blood groups in Nigeria: a review. Egypt J Med Human Genetics. 2017;18(3):205–210. DOI:https://doi.org/10.1016/j.ejmhg.2016.10.004
Oladele EO, Yahaya TO, Adewunmi OO, David B, Oladipo AJ. Distribution of ABO/rhesus blood groups among hepatitis B virus (HBV) positive patients in Lagos, South-Western, Nigeria. FUDMA J Sci. 2020:4(3):196–200.
Qureshi MA, Bhatti R. Frequency of ABO blood groups among the diabetes mellitus type 2 patients. J Coll Phys Surg Pak. 2003;13(8):453–455.
Bener A, Yousafzai M. “The distribution of the ABO blood groups among the diabetes mellitus patients,” Nigerian journal of clinical practice. 2014;17(5):565–568.
Zahid H, Yahyaoui A, Uwingabiye J, El Khazraji A, El Hadef R, Messaoudi N. Phenotypic and allelic distribution of ABO and Rh-D blood Groups in Blood Transfusion Center of Avicenna Military Hospital, Marrakech, Morocco. Int J Med Health Res. 2016;2(1):1–9.
Abdel Ghafar MT, Shalaby KH, Okda HI, Rizk, FH. Association of ABCA1 (C69T) gene polymorphism with dyslipidemia and type 2 diabetes among the Egyptian population. Meta Gene. 2020;25:100714.
DOI:https://doi.org/10.1016/j.mgene.2020.100714
Yahaya T, Oladele E, Fatodu I, Abdulazeez A, Yeldu Y. Concentrations and health risk evaluation of heavy metals and microorganisms in groundwater in Lagos, Southwest Nigeria. Journal of Advances in Environmental Health Research. 2020;8(3): 234–242. DOI:https://doi.org/10.22102/jaehr.2020.245629.1183
Yahaya T, Obaroh IO, Oladele EO. The roles of environmental pollutants in the pathogenesis and prevalence of diabetes: a review. J Appl Sci Environ Manag. 2017; 21(1):5–8. DOI:https://doi.org/10.4314/jasem.v21i1.1
Shittu RO, Kasali FO, Biliaminu SA, Odeigah LO, Sule AG, Musah Y. Prevalence of diabetes and pre-diabetes in Oke-Ogun Region of Oyo State, Nigeria. J Med Rese Health Educ. 2017;1:1.
Doig K, Zhang B. A Methodical Approach to Interpreting the Red Blood Cell Parameters of the Complete Blood Count. Am Soc Clin Lab Sci. 2017;30(3):173–85.
Vinupritha P, Hariharan M, Kathirvelu D, Chinnadurai S. Estimation of HbA1C using CBC in the diagnosis of diabetes. Asian J Pharm Clin Res. 2017;10(9):214–8.
Turpin C, Catan A, Guerin-Dubourg A, Debussche X, Bravo S, Álvarez El. Enhanced oxidative stress and damage in glycated erythrocytes. PLoS One. 2020.
Juhi A. Comparative study of erythrocyte fragility in diabetes mellitus and nondiabetes Mellitus. Int J Med Res Heal Sci. 2015;4(1):183–5.
Li Q, Yang LZ. Hemoglobin A1c level higher than 9.05% causes a significant impairment of erythrocyte deformability in DM. Acta Endocrinol. 2018;14(1):66–75.
Anderson JL, Ronnow BS, Horne BD, Carlquist JF, May HT. Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol. 2007;99:169-174.
Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009;277:103-108.
Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009;169:515-523.
Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med. 2007;169: 588-594.
Cheesbrough M. District Laboratory Practice in Tropical Countries. 2nd Edition, Cambridge University Press, Cambridge, United Kingdom; 2010.
Sukalingam K, Ganesan K. “Rh blood groups associated with risk to obesity and diabetes mellitus: a report on Punjabi population in Selangor, Malaysia,” International Journal of Integrative Medical Sciences. 2015;2(4): 105–109.
Dali SM, Aour M. Belmokhtar, AF Belmokhtar R, Boazza F. “The relationship between ABO/Rh blood groups and type 2 diabetes mellitus in Maghnia, western Algeria,” South African Family Practice. 2014;53(6):568–572.
Moinzadeh F, Najafabady GM, Toghiani A. “Type 2 diabetes mellitus and ABO/Rh blood groups,” Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2014;19(4):382.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, & IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes research and clinical practice. 2019;157:107843.
Waseem AG, Iqbal M, Khan OA, Tahir M. Association of diabetes mellitus with ABO and Rh blood groups. Ann Pak Inst Med Sci. 2012;8(2):134-6.
Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi RL, Constantine GR, Katulanda P. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetology & Metabolic Syndrome. 2012 Dec;4(1):1-2.